Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

NCT04692688 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Retinopathy
Diabetic Macular Edema
NPDR - Non Proliferative Diabetic Retinopathy
PDR - Proliferative Diabetic Retinopathy

Interventions

DRUG: APX3330
DRUG: Placebo

Sponsor

Ocuphire Pharma, Inc.